At Ruikang's prosthetic body research and development base, the main team is Professor Li Yuntong, who was poached from MIT, responsible for the research and development of mechanical engineering.

Professor Yun Heng led his team to be responsible for some auxiliary work in biological histology and some scientific research on human neurons, mainly doing biological work.

In fact, they did a good job. Although the research process was a bit hindrance, at least the progress was still increasing little by little, and the data collection and simulation of arm neurons was also quite smooth.

But Yun Heng really doesn't like this job. Not only him, but his scientific research team is basically not interested in this project, and this project is not their main research direction.

It's like asking a group of excavators to turn on the bulldozer. Although they can also drive it, it's not what they learn or what they like.

After following Chen Changan to attend the Nobel Prize Ceremony and seeing and hearing the awards from several Nobel Prize winners with his own eyes, Yun Heng once again strengthened his idea of ​​continuing to move forward on the road of genetics.

So after returning to China, he proposed to Chen Changan to change his position.

He and his scientific research team are both engaged in cytology and genetics, and they are really not suitable for working on the biological side of mechanical prosthesis.

However, half of the researchers in Wang Jia's team are professionals in neurology, especially Fu Yi, who is well-known in human neurology in China. They are more suitable for taking over the nerve simulation and connection work of mechanical prosthetics.

After listening carefully to Yun Heng's ideas, Chen Changan chose to respect his ideas.

"Professor Yun, do you have any ideas on your next research goals?"

Faced with Chen Changan's problem, Yun Heng said confidently: "I want to continue to conduct in-depth research on gene editing technology. I think the CRISPR-Cas system has very high potential and can achieve healing ability that conventional treatment technology cannot achieve in terms of genetic diseases and rare diseases!"

Most rare diseases and genetic diseases are related to genes and are almost incurable. Even if a few rare diseases can be treated, they can only alleviate and delay the onset of the disease.

However, at the moment when gene editing technology is gradually maturing, many rare and genetic diseases have shown a dawn of cure!

What Yun Heng wants to do is rely on the latest CRISPR-Cas gene editing tools to develop more gene therapy drugs to fundamentally cure and eliminate some rare and genetic diseases that can only wait for death!

But after listening to his words, Chen Changan frowned.

Yun Heng’s idea is very good, but it’s a bit too empty.

There are currently five or six thousand rare diseases in the world, most of which are related to genes. However, the reason why these rare diseases are called rare diseases is because they are not very common. Many rare diseases may have only hundreds or thousands of patients around the world.

For these hundreds or thousands of patients, very high energy and money are invested in developing specific special drugs, which is not only time-consuming and labor-intensive, but also a very waste of precious golden period of scientific research.

It’s not that Chen Changan doesn’t value these rare patients, and thinks they are small and insignificant, but that there are more urgent patients waiting to be rescued.

After thinking for a long time, Chen Changan pondered and said to Yun Heng carefully: "Professor Yun, in principle, I agree with your ideas very much, and I am willing to support you in continuing to invest energy and money in the field of gene editing to increase research."

"But in specific research directions, I have some other views."

"Compared with rare diseases, I think some common diseases are more urgently needed to have effective treatment options."

"Like AIDS!"

"As far as I know, gene editing technology has a great possibility and can make great contributions to the fight against AIDS!"

"How about we try to cure AIDS in gene editing technology? "
Chapter completed!